Aviva’s Teva Pharmaceuticals TEVA Stock Holding History

Aviva’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$39.2M	Buy	1,300,604 +192,142	+17%	+$6.18M	0.07%	267
2025 Q4	$34.6M	Sell	1,108,462 -15,091	-1%	-$372K	0.06%	284
2025 Q3	$22.7M	Buy	+1,123,553	New	+$19.7M	0.04%	346
2019 Q4	–	Sell	-15,885	Closed	-$109K	–	954
2019 Q3	$109K	Hold	15,885	–	–	﹤0.01%	786
2019 Q2	$147K	Hold	15,885	–	–	﹤0.01%	786
2019 Q1	$249K	Hold	15,885	–	–	﹤0.01%	739
2018 Q4	$245K	Sell	15,885 -1,500	-9%	-$30.8K	﹤0.01%	736
2018 Q3	$374K	Hold	17,385	–	–	﹤0.01%	731
2018 Q2	$423K	Hold	17,385	–	–	﹤0.01%	718
2018 Q1	$297K	Hold	17,385	–	–	﹤0.01%	712
2017 Q4	$329K	Hold	17,385	–	–	﹤0.01%	714
2017 Q3	$306K	Hold	17,385	–	–	﹤0.01%	719
2017 Q2	$578K	Hold	17,385	–	–	﹤0.01%	725
2017 Q1	$558K	Hold	17,385	–	–	﹤0.01%	737
2016 Q4	$631K	Hold	17,385	–	–	﹤0.01%	723
2016 Q3	$800K	Hold	17,385	–	–	0.01%	743
2016 Q2	$873K	Buy	17,385 +350	+2%	+$18.6K	0.01%	709
2016 Q1	$912K	Hold	17,035	–	–	0.01%	730
2015 Q4	$1.12M	Hold	17,035	–	–	0.01%	738
2015 Q3	$962K	Hold	17,035	–	–	0.01%	753
2015 Q2	$1.01M	Hold	17,035	–	–	0.01%	748
2015 Q1	$1.06M	Hold	17,035	–	–	0.01%	775
2014 Q4	$980K	Hold	17,035	–	–	0.01%	786
2014 Q3	$916K	Hold	17,035	–	–	0.01%	796
2014 Q2	$893K	Hold	17,035	–	–	0.01%	787
2014 Q1	$900K	Sell	17,035 -148,562	-90%	-$6.87M	0.01%	770
2013 Q4	$6.64M	Buy	165,597 +23,870	+17%	+$940K	0.06%	367
2013 Q3	$5.36M	Buy	141,727 +1,378	+1%	+$53.8K	0.05%	393
2013 Q2	$5.5M	Buy	+140,349	New	+$5.47M	0.06%	336

Other funds holding TEVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Aviva's TEVA Position: Q1 2026 in Review

Aviva increased its Teva Pharmaceuticals (TEVA) stake by 17% in Q1 2026, buying an estimated $6.18M and bringing the position to 1,300,604 shares worth $39.2M. The position accounts for 0.07% of the portfolio, ranked #267.

Aviva first reported a position in TEVA in Q2 2013 and has held it in 29 quarters since. 650 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

Aviva held 1,300,604 shares of Teva Pharmaceuticals worth $39.2M as of Q1 2026.
Aviva bought 192,142 Teva Pharmaceuticals shares in Q1 2026, an estimated $6.18M.
Teva Pharmaceuticals made up 0.07% of Aviva's portfolio in Q1 2026, its #267 holding.
Aviva first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 29 quarters since.
650 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on Aviva's 13F filing for Q1 2026, filed 14 May 2026.